Last reviewed 2026-04-20 · How we verify

Pf-08049820 (pf-08049820)

At a glance

Approved indications

• Indication not found
• Indication not found

Common side effects

No common side effects on file.

Drug interactions

• Warfarin
• Aspirin
• Pentoxifylline
• Dipyridamole
• Clopidogrel
• Ticlopidine
• Alteplase
• Urokinase
• Streptokinase
• Tenecteplase
• Abciximab
• Eptifibatide

Key clinical trials

• A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema (PHASE2)
• A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults (PHASE1)
• A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults. (PHASE1)
• A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants (PHASE1)
• A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Pf-08049820 CI brief — competitive landscape report
• Pf-08049820 updates RSS · CI watch RSS
• Pfizer portfolio CI